Charles Berkman
Director/Board Member at VERNALIS
Net worth: 3 M $ as of 2024-03-30
Profile
Charles Stuart Berkman is currently working as the Secretary & Director at Ligand UK Ltd., as well as the Secretary & Director at Ligand UK Research Ltd.
He is also serving as the Secretary, Director, Senior VP & General Counsel at Pelican Inc. Additionally, he holds the position of Secretary & Director at Ligand UK Group Ltd.
and Secretary & Chief Legal Officer at OmniAb Operations, Inc. Mr. Berkman will also be assuming the role of Secretary & Chief Legal Officer at OmniAb, Inc. starting in 2022.
In the past, Mr. Berkman worked as the Secretary, Senior Vice President & General Counsel at Ligand Pharmaceuticals, Inc. from 2001 to 2022.
Prior to that, he was an Attorney at Baker & McKenzie LLP (Illinois) from 2000 to 2001, and at Lyon & Lyon, Inc. from 1993 to 2000.
Mr. Berkman completed his undergraduate studies at The University of Texas at Austin and obtained his graduate degree from The University of Texas School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-13 | 23,825 ( 0.13% ) | 2 M $ | 2024-03-30 | |
OMNIAB, INC.
0.25% | 2024-04-07 | 292,617 ( 0.25% ) | 2 M $ | 2024-03-30 |
Charles Berkman active positions
| Companies | Position | Start |
|---|---|---|
| VERNALIS | Director/Board Member | 2018-10-11 |
| PFENEX INC. | Director/Board Member | 2020-09-30 |
| OMNIAB, INC. | General Counsel | 2022-02-28 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Corporate Secretary | 2010-01-28 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding private company. The company is based in Cambridge, UK. | Director/Board Member | 2018-10-11 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | General Counsel | 2022-02-28 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The private company is based in London, UK. Founded in 1995. | Director/Board Member | 2018-10-11 |
Former positions of Charles Berkman
| Companies | Position | End |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 2022-10-31 |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 2001-10-31 |
| ░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Charles Berkman
| The University of Texas at Austin | Undergraduate Degree |
| The University of Texas School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Private companies | 8 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | Commercial Services |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The private company is based in London, UK. Founded in 1995. | Health Technology |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | Commercial Services |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding private company. The company is based in Cambridge, UK. | Finance |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Charles Berkman
